menu
    • menu

    Company profile for Pharming

    NEW Drugs in Dev: 6
    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Pharming is a specialty pharmaceutical company developing innovative products for the safe, effective treatment of rare diseases and unmet medical needs. We are committed to transforming the future for our patients. We develop innovative products for the treatment of unmet medical needs. Pharming’s lead product, RUCONEST® (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute her...
    Pharming is a specialty pharmaceutical company developing innovative products for the safe, effective treatment of rare diseases and unmet medical needs. We are committed to transforming the future for our patients. We develop innovative products for the treatment of unmet medical needs. Pharming’s lead product, RUCONEST® (conestat alfa) is a recombinant human C1 esterase inhibitor approved for the treatment of acute hereditary angioedema (“HAE”) attacks in patients in Europe, the US, Israel and South Korea. The product is available on a named-patient basis in other territories where it has not yet obtained marketing authorization.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    PharmingNetherlands1 Flag
    Country
    Country
    Netherlands
    Address
    Address
    Pharming Group NV Vondellaan 47 2332 AA Leiden
    Telephone
    Telephone
    +31 (0)71 5247 400
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.pharming.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    ASPEN

    ASPEN

    Not Confirmed

    envelop Contact Supplier

    ASPEN

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pharming Group Unveils 2026 Guidance, Rare Disease Pipeline
    Pharming Group Unveils 2026 Guidance, Rare Disease Pipeline

    03 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/03/3230713/0/en/Pharming-Group-announces-2026-financial-guidance-and-highlights-rare-disease-pipeline-at-Investor-Day.html

    GLOBENEWSWIRE
    03 Feb 2026
    Share Share
    Pharming Group Gets FDA Complete Response Letter For Joenja
    Pharming Group Gets FDA Complete Response Letter For Joenja

    01 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/01/3229924/0/en/Pharming-Group-receives-Complete-Response-Letter-from-U-S-FDA-for-sNDA-for-Joenja-leniolisib-in-children-aged-4-to-11-years-with-APDS.html

    GLOBENEWSWIRE
    01 Feb 2026
    Share Share
    Pharming Group Joins Oppenheimer Rare Disease Summit
    Pharming Group Joins Oppenheimer Rare Disease Summit

    08 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/08/3201210/0/en/Pharming-Group-to-participate-in-Oppenheimer-Movers-in-Rare-Disease-Summit.html

    GLOBENEWSWIRE
    08 Dec 2025
    Share Share
    Pharming Group Joins Fireside Chat At Jefferies Global
    Pharming Group Joins Fireside Chat At Jefferies Global

    30 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/30/3177070/0/en/Pharming-Group-to-participate-in-Fireside-Chat-at-Jefferies-Global-Healthcare-Conference-in-London.html

    GLOBENEWSWIRE
    30 Oct 2025
    Share Share
    Pharming Group To Release Q3 2025 Financial Results And Business
    Pharming Group To Release Q3 2025 Financial Results And Business

    23 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/23/3171694/0/en/Pharming-Group-to-report-third-quarter-2025-financial-results-and-provide-business-update-on-November-6.html

    GLOBENEWSWIRE
    23 Oct 2025
    Share Share
    Pharming Group Presents New Rare Disease Data At 2025 ACAAI
    Pharming Group Presents New Rare Disease Data At 2025 ACAAI

    20 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/20/3169083/0/en/Pharming-Group-announces-presentations-at-2025-ACAAI-Annual-Scientific-Meeting-showcasing-new-data-across-rare-disease-portfolio.html

    GLOBENEWSWIRE
    20 Oct 2025
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search